Point of Care Diagnostics Market

1. Executive Summary
    1.1. Key Market Insights

2. Introduction
    2.1. Study Objectives
    2.2. Market Definition
           2.2.1. Market Covered
           2.2.2. Regional Coverage
           2.2.3. Study Years & Currency
    2.3. Market Stakeholders
    2.4. Key Questions this Study will Answer
    2.5. GMI Research’s Approach & Methodology
           2.5.1. Research Data
           2.5.2. Primary Data
           2.5.3. Demand Side and Supply Side Analysis
           2.5.4. Market Size Estimation
           2.5.5. Research Assumptions

3. Global Point of Care (POC) Diagnostics Market- Overview
    3.1. Introduction
    3.2. Market Segmentation
    3.3. Value Chain Analysis
    3.4. Market Drivers
    3.5. Market Restraints
    3.6. Market Trends

4. Global Point of Care (POC) Diagnostics Market Revenue Forecast till 2027

5. Global Point of Care (POC) Diagnostics Market by Platform Revenue Forecast till 2027
    5.1. Dipsticks
    5.2. Lateral Flow Assays
    5.3. Molecular Diagnostics
    5.4. Microfluidics
    5.5. Immunoassays

6. Global Point of Care (POC) Diagnostics Market by Mode of Purchase Revenue Forecast till 2027
    6.1. OTC Products
    6.2. Prescription-Based Products

7. Global Point of Care (POC) Diagnostics Market by Product Revenue Forecast till 2027
    7.1. Cardiometabolic Monitoring Products
           7.1.1. Blood Gas/Electrolyte Testing Products
           7.1.2. Cardiac Marker Testing Products
           7.1.3. Hba1c Testing Products
    7.2. Glucose Monitoring Products
           7.2.1. Meters
           7.2.2. Strips
           7.2.3. Lancets & Lancing Devices
    7.3. Infectious Disease Testing Products
           7.3.1. HIV Testing Products
           7.3.2. Influenza Testing Products
           7.3.3. Sexually Transmitted Disease Testing Products
           7.3.4. Hepatitis C Testing Products
           7.3.5. Respiratory Infection Testing Products
           7.3.6. Healthcare-Associated Infection Testing Products
           7.3.7. Tropical Disease Testing Products
           7.3.8. Other Infectious Disease Testing Products
    7.4. Coagulation Monitoring Products
           7.4.1. Act/Aptt Testing Products
           7.4.2. Pt/Inr Testing Products
    7.5. Tumor/Cancer Marker Testing Products
    7.6. Pregnancy & Fertility Testing Products
           7.6.1. Fertility Testing Products
           7.6.2. Pregnancy Testing Products
    7.7. Cholesterol Testing Products
    7.8. Urinalysis Testing Products
    7.9. Drugs-of-Abuse Testing Products
    7.10. Hematology Testing Products
    7.11. Fecal Occult Testing Products
    7.12. Other POC Products

8. Global Point of Care (POC) Diagnostics Market by End User Revenue Forecast till 2027
    8.1. Hospitals/Critical Care Centers
    8.2. Professional Diagnostic Centers
    8.3. Research Laboratories
    8.4. Home Care Settings
    8.5. Other End Users

9. Global Point of Care (POC) Diagnostics Market by Region Forecast till 2027
    9.1. North America Point of Care (POC) Diagnostics Market Revenue Forecast till 2027
    (Option 1: As a part of the free 25% customization)
           9.1.1. North America Point of Care (POC) Diagnostics Market by Platform
                     9.1.1.1. Dipsticks
                     9.1.1.2. Lateral Flow Assays
                     9.1.1.3. Molecular Diagnostics
                     9.1.1.4. Microfluidics
                     9.1.1.5. Immunoassays
           9.1.2. North America Point of Care (POC) Diagnostics Market by Mode of Purchase
                     9.1.2.1. OTC Products
                     9.1.2.2. Prescription-Based Products
           9.1.3. North America Point of Care (POC) Diagnostics Market by Product
                     9.1.3.1. Cardiometabolic Monitoring Products
                                     9.1.3.1.1. Blood Gas/Electrolyte Testing Products
                                     9.1.3.1.2. Cardiac Marker Testing Products
                                     9.1.3.1.3. Hba1c Testing Products
                     9.1.3.2. Glucose Monitoring Products
                                     9.1.3.2.1. Meters
                                     9.1.3.2.2. Strips
                                     9.1.3.2.3. Lancets & Lancing Devices
                     9.1.3.3. Infectious Disease Testing Products
                                     9.1.3.3.1. HIV Testing Products
                                     9.1.3.3.2. Influenza Testing Products
                                     9.1.3.3.3. Sexually Transmitted Disease Testing Products
                                     9.1.3.3.4. Hepatitis C Testing Products
                                     9.1.3.3.5. Respiratory Infection Testing Products
                                     9.1.3.3.6. Healthcare-Associated Infection Testing Products
                                     9.1.3.3.7. Tropical Disease Testing Products
                                     9.1.3.3.8. Other Infectious Disease Testing Products
                     9.1.3.4. Coagulation Monitoring Products
                                     9.1.3.4.1. Act/Aptt Testing Products
                                     9.1.3.4.2. Pt/Inr Testing Products
                     9.1.3.5. Tumor/Cancer Marker Testing Products
                     9.1.3.6. Pregnancy & Fertility Testing Products
                                     9.1.3.6.1. Fertility Testing Products
                                     9.1.3.6.2. Pregnancy Testing Products
                     9.1.3.7. Cholesterol Testing Products
                     9.1.3.8. Urinalysis Testing Products
                     9.1.3.9. Drugs-of-Abuse Testing Products
                     9.1.3.10. Hematology Testing Products
                     9.1.3.11. Fecal Occult Testing Products
                     9.1.3.12. Other POC Products
           9.1.4. North America Point of Care (POC) Diagnostics Market by End User
                     9.1.4.1. Hospitals/Critical Care Centers
                     9.1.4.2. Professional Diagnostic Centers
                     9.1.4.3. Research Laboratories
                     9.1.4.4. Home Care Settings
                     9.1.4.5. Other End Users
           9.1.5. US Point of Care (POC) Diagnostics Market All-Up
           9.1.6. Canada Point of Care (POC) Diagnostics Market All-Up
    9.2. Europe Point of Care (POC) Diagnostics Market Revenue Forecast till 2027
    (Option 2: As a part of the free 25% customization)
           9.2.1. Europe Point of Care (POC) Diagnostics Market by Platform
                     9.2.1.1. Dipsticks
                     9.2.1.2. Lateral Flow Assays
                     9.2.1.3. Molecular Diagnostics
                     9.2.1.4. Microfluidics
                     9.2.1.5. Immunoassays
           9.2.2. Europe Point of Care (POC) Diagnostics Market by Mode of Purchase
                     9.2.2.1. OTC Products
                     9.2.2.2. Prescription-Based Products
           9.2.3. Europe Point of Care (POC) Diagnostics Market by Product
                     9.2.3.1. Cardiometabolic Monitoring Products
                                     9.2.3.1.1. Blood Gas/Electrolyte Testing Products
                                     9.2.3.1.2. Cardiac Marker Testing Products
                                     9.2.3.1.3. Hba1c Testing Products
                     9.2.3.2. Glucose Monitoring Products
                                     9.2.3.2.1. Meters
                                     9.2.3.2.2. Strips
                                     9.2.3.2.3. Lancets & Lancing Devices
                     9.2.3.3. Infectious Disease Testing Products
                                     9.2.3.3.1. HIV Testing Products
                                     9.2.3.3.2. Influenza Testing Products
                                     9.2.3.3.3. Sexually Transmitted Disease Testing Products
                                     9.2.3.3.4. Hepatitis C Testing Products
                                     9.2.3.3.5. Respiratory Infection Testing Products
                                     9.2.3.3.6. Healthcare-Associated Infection Testing Products
                                     9.2.3.3.7. Tropical Disease Testing Products
                                     9.2.3.3.8. Other Infectious Disease Testing Products
                     9.2.3.4. Coagulation Monitoring Products
                                     9.2.3.4.1. Act/Aptt Testing Products
                                     9.2.3.4.2. Pt/Inr Testing Products
                     9.2.3.5. Tumor/Cancer Marker Testing Products
                     9.2.3.6. Pregnancy & Fertility Testing Products
                                     9.2.3.6.1. Fertility Testing Products
                                     9.2.3.6.2. Pregnancy Testing Products
                     9.2.3.7. Cholesterol Testing Products
                     9.2.3.8. Urinalysis Testing Products
                     9.2.3.9. Drugs-of-Abuse Testing Products
                     9.2.3.10. Hematology Testing Products
                     9.2.3.11. Fecal Occult Testing Products
                     9.2.3.12. Other POC Products
           9.2.4. Europe Point of Care (POC) Diagnostics Market by End User
                     9.2.4.1. Hospitals/Critical Care Centers
                     9.2.4.2. Professional Diagnostic Centers
                     9.2.4.3. Research Laboratories
                     9.2.4.4. Home Care Settings
                     9.2.4.5. Other End Users
           9.2.5. UK Point of Care (POC) Diagnostics Market All-Up
           9.2.6. Germany Point of Care (POC) Diagnostics Market All-Up
           9.2.7. France Point of Care (POC) Diagnostics Market All-Up
           9.2.8. Spain Point of Care (POC) Diagnostics Market All-Up
           9.2.9. Rest of Europe Point of Care (POC) Diagnostics Market All-Up
    9.3. Asia-Pacific Point of Care (POC) Diagnostics Market Revenue Forecast till 2027
    (Option 3: As a part of the free 25% customization)
           9.3.1. Asia-Pacific Point of Care (POC) Diagnostics Market by Platform
                     9.3.1.1. Dipsticks
                     9.3.1.2. Lateral Flow Assays
                     9.3.1.3. Molecular Diagnostics
                     9.3.1.4. Microfluidics
                     9.3.1.5. Immunoassays
           9.3.2. Asia-Pacific Point of Care (POC) Diagnostics Market by Mode of Purchase
                     9.3.2.1. OTC Products
                     9.3.2.2. Prescription-Based Products
           9.3.3. Asia-Pacific Point of Care (POC) Diagnostics Market by Product
                     9.3.3.1. Cardiometabolic Monitoring Products
                                     9.3.3.1.1. Blood Gas/Electrolyte Testing Products
                                     9.3.3.1.2. Cardiac Marker Testing Products
                                     9.3.3.1.3. Hba1c Testing Products
                     9.3.3.2. Glucose Monitoring Products
                                     9.3.3.2.1. Meters
                                     9.3.3.2.2. Strips
                                     9.3.3.2.3. Lancets & Lancing Devices
                     9.3.3.3. Infectious Disease Testing Products
                                     9.3.3.3.1. HIV Testing Products
                                     9.3.3.3.2. Influenza Testing Products
                                     9.3.3.3.3. Sexually Transmitted Disease Testing Products
                                     9.3.3.3.4. Hepatitis C Testing Products
                                     9.3.3.3.5. Respiratory Infection Testing Products
                                     9.3.3.3.6. Healthcare-Associated Infection Testing Products
                                     9.3.3.3.7. Tropical Disease Testing Products
                                     9.3.3.3.8. Other Infectious Disease Testing Products
                     9.3.3.4. Coagulation Monitoring Products
                                     9.3.3.4.1. Act/Aptt Testing Products
                                     9.3.3.4.2. Pt/Inr Testing Products
                     9.3.3.5. Tumor/Cancer Marker Testing Products
                     9.3.3.6. Pregnancy & Fertility Testing Products
                                     9.3.3.6.1. Fertility Testing Products
                                     9.3.3.6.2. Pregnancy Testing Products
                     9.3.3.7. Cholesterol Testing Products
                     9.3.3.8. Urinalysis Testing Products
                     9.3.3.9. Drugs-of-Abuse Testing Products
                     9.3.3.10. Hematology Testing Products
                     9.3.3.11. Fecal Occult Testing Products
                     9.3.3.12. Other POC Products
           9.3.4. Asia-Pacific Point of Care (POC) Diagnostics Market by End User
                     9.3.4.1. Hospitals/Critical Care Centers
                     9.3.4.2. Professional Diagnostic Centers
                     9.3.4.3. Research Laboratories
                     9.3.4.4. Home Care Settings
                     9.3.4.5. Other End Users
           9.3.5. China Point of Care (POC) Diagnostics Market All-Up
           9.3.6. India Point of Care (POC) Diagnostics Market All-Up
           9.3.7. Japan Point of Care (POC) Diagnostics Market All-Up
           9.3.8. Rest of APAC Point of Care (POC) Diagnostics Market All-Up
    9.4. RoW Point of Care (POC) Diagnostics Market Revenue Forecast till 2027
    (Option 4: As a part of the free 25% customization)
           9.4.1. RoW Point of Care (POC) Diagnostics Market by Platform
                     9.4.1.1. Dipsticks
                     9.4.1.2. Lateral Flow Assays
                     9.4.1.3. Molecular Diagnostics
                     9.4.1.4. Microfluidics
                     9.4.1.5. Immunoassays
           9.4.2. RoW Point of Care (POC) Diagnostics Market by Mode of Purchase
                     9.4.2.1. OTC Products
                     9.4.2.2. Prescription-Based Products
           9.4.3. RoW Point of Care (POC) Diagnostics Market by Product
                     9.4.3.1. Cardiometabolic Monitoring Products
                                     9.4.3.1.1. Blood Gas/Electrolyte Testing Products
                                     9.4.3.1.2. Cardiac Marker Testing Products
                                     9.4.3.1.3. Hba1c Testing Products
                     9.4.3.2. Glucose Monitoring Products
                                     9.4.3.2.1. Meters
                                     9.4.3.2.2. Strips
                                     9.4.3.2.3. Lancets & Lancing Devices
                     9.4.3.3. Infectious Disease Testing Products
                                     9.4.3.3.1. HIV Testing Products
                                     9.4.3.3.2. Influenza Testing Products
                                     9.4.3.3.3. Sexually Transmitted Disease Testing Products
                                     9.4.3.3.4. Hepatitis C Testing Products
                                     9.4.3.3.5. Respiratory Infection Testing Products
                                     9.4.3.3.6. Healthcare-Associated Infection Testing Products
                                     9.4.3.3.7. Tropical Disease Testing Products
                                     9.4.3.3.8. Other Infectious Disease Testing Products
                     9.4.3.4. Coagulation Monitoring Products
                                     9.4.3.4.1. Act/Aptt Testing Products
                                     9.4.3.4.2. Pt/Inr Testing Products
                     9.4.3.5. Tumor/Cancer Marker Testing Products
                     9.4.3.6. Pregnancy & Fertility Testing Products
                                     9.4.3.6.1. Fertility Testing Products
                                     9.4.3.6.2. Pregnancy Testing Products
                     9.4.3.7. Cholesterol Testing Products
                     9.4.3.8. Urinalysis Testing Products
                     9.4.3.9. Drugs-of-Abuse Testing Products
                     9.4.3.10. Hematology Testing Products
                     9.4.3.11. Fecal Occult Testing Products
                     9.4.3.12. Other POC Products
           9.4.4. RoW Point of Care (POC) Diagnostics Market by End User
                     9.4.4.1. Hospitals/Critical Care Centers
                     9.4.4.2. Professional Diagnostic Centers
                     9.4.4.3. Research Laboratories
                     9.4.4.4. Home Care Settings
                     9.4.4.5. Other End Users
           9.4.5. Brazil Point of Care (POC) Diagnostics Market All-Up
           9.4.6. South Africa Point of Care (POC) Diagnostics Market All-Up
           9.4.7. Saudi Arabia Point of Care (POC) Diagnostics Market All-Up
           9.4.8. UAE Point of Care (POC) Diagnostics Market All-Up
           9.4.9. Rest of world (remaining countries of the LAMEA region) Point of Care (POC) Diagnostics Market All-Up

10. Competitive Landscape Analysis
    10.1. Porter’s Five Forces Analysis
    10.2. Industry – Competitive Landscape
    10.3. Market Presence (Intensity Mapping)
    10.4. Key Strategic Market Developments

11. Company Profiles (Option 5: Free 25% Customization - Profiles of 5 Additional Companies of your Choice)
    11.1. BD
           11.1.1. Company Overview
           11.1.2. Key Executives
           11.1.3. Footprint & Employee Strength
           11.1.4. Product Offerings
           11.1.5. Financials
           11.1.6. Key Company Developments
    11.2. Abbott
           11.2.1. Company Overview
           11.2.2. Key Executives
           11.2.3. Footprint & Employee Strength
           11.2.4. Product Offerings
           11.2.5. Financials
           11.2.6. Key Company Developments
    11.3. Danaher
           11.3.1. Company Overview
           11.3.2. Key Executives
           11.3.3. Footprint & Employee Strength
           11.3.4. Product Offerings
           11.3.5. Financials
           11.3.6. Key Company Developments
    11.4. Chembio Diagnostics, Inc.
           11.4.1. Company Overview
           11.4.2. Key Executives
           11.4.3. Footprint & Employee Strength
           11.4.4. Product Offerings
           11.4.5. Financials
           11.4.6. Key Company Developments
    11.5. F. Hoffmann-La Roche Ltd
           11.5.1. Company Overview
           11.5.2. Key Executives
           11.5.3. Footprint & Employee Strength
           11.5.4. Product Offerings
           11.5.5. Financials
           11.5.6. Key Company Developments
    11.6. Johnson & Johnson Services, Inc.
           11.6.1. Company Overview
           11.6.2. Key Executives
           11.6.3. Footprint & Employee Strength
           11.6.4. Product Offerings
           11.6.5. Financials
           11.6.6. Key Company Developments
    11.7. EKF Diagnostics
           11.7.1. Company Overview
           11.7.2. Key Executives
           11.7.3. Footprint & Employee Strength
           11.7.4. Product Offerings
           11.7.5. Financials
           11.7.6. Key Company Developments
    11.8. Siemens Healthcare Private Limited
           11.8.1. Company Overview
           11.8.2. Key Executives
           11.8.3. Footprint & Employee Strength
           11.8.4. Product Offerings
           11.8.5. Financials
           11.8.6. Key Company Developments
    11.9. Trinity Biotech
           11.9.1. Company Overview
           11.9.2. Key Executives
           11.9.3. Footprint & Employee Strength
           11.9.4. Product Offerings
           11.9.5. Financials
           11.9.6. Key Company Developments
    11.10. Quidel Corporation
           11.10.1. Company Overview
           11.10.2. Key Executives
           11.10.3. Footprint & Employee Strength
           11.10.4. Product Offerings
           11.10.5. Financials
           11.10.6. Key Company Developments

12. About GMI Research

*Details on Financials might not be available in case of unlisted/private companies.